Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Government of the People's Republic of China - First Medical Center, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, BeiGene (Shanghai) Co., Ltd, BeiGene (Shanghai) Co., Ltd, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology and Government of the People's Republic of China - Department of Oncology

Zhejiang University, Sun Yat-sen University (SYSU), Sichuan Cancer Hospital, Fujian Medical University - Department of Medical Oncology, Anhui Provincial Hospital, Hunan Traditional Chinese Medical College, Tangshan People’s Hospital, Government of the People's Republic of China - Department of Oncology, Nanjing Medical University - Department of Oncology, Shandong Provincial Cancer Hospital, Henan University of Science and Technology, China Medical University, Huazhong University of Science and Technology, Tianjin Medical University - Tianjin Cancer Institute, Capital Medical University, Shandong University, Shandong First Medical University, Zhengzhou University, Shandong University, Central South University - Department of Medical Oncology, Anhui Medical University, Huazhong University of Science and Technology - Department of Medical Oncology, Huazhong University of Science and Technology - Hubei Cancer Hospital, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd and Zhejiang University - Department of Colorectal Surgery and Oncology

Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, 3D Medicines, Inc., University of Texas at Houston - Department of Genomic Medicine, Government of the People's Republic of China - Department of Oncology and Government of the People's Republic of China - Department of Oncology

Government of the People's Republic of China - Department of Oncology, Nankai University, Government of the People's Republic of China - Chinese PLA General Hospital, Beijing University of Chinese Medicine - Dongzhimen Hospital, Nankai University, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Beijing University of Chinese Medicine - Dongzhimen Hospital, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology and Beijing Institute of Biotechnology - Department of Medical Molecular Biology